| Name | Title | Contact Details |
|---|---|---|
Rakesh Surve |
Director, Information Security and Services | Profile |
Health2047 Inc. is a Silicon Valley integrated innovation enterprise whose mission is to develop, guide, and commercialize disruptive ideas that enhance — at the system level— the practice of healthcare.
WellAWARE Systems, in partnership with Volunteers of America (VOA) and The Evangelical Lutheran Good Samaritan Society (GSS), offers the opportunity for enhanced quality of life for our aging population through an innovative approach to wellness and safety for senior living.
mdINR is a New Windsor, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Ampronix is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Irvine, CA. To find more information about Ampronix, please visit www.ampronix.com